These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21813277)

  • 1. Discovery and hit-to-lead optimization of novel allosteric glucokinase activators.
    Lang M; Seifert MH; Wolf KK; Aschenbrenner A; Baumgartner R; Wieber T; Trentinaglia V; Blisse M; Tajima N; Yamashita T; Vitt D; Noda H
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5417-22. PubMed ID: 21813277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a new class of glucokinase activators through structure-based design.
    Hinklin RJ; Boyd SA; Chicarelli MJ; Condroski KR; DeWolf WE; Lee PA; Lee W; Singh A; Thomas L; Voegtli WC; Williams L; Aicher TD
    J Med Chem; 2013 Oct; 56(19):7669-78. PubMed ID: 24015910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of a novel series of glucokinase activators based on a pyrazolopyrimidine scaffold.
    Bonn P; Brink DM; Fägerhag J; Jurva U; Robb GR; Schnecke V; Svensson Henriksson A; Waring MJ; Westerlund C
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7302-5. PubMed ID: 23149230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators.
    Cheruvallath ZS; Gwaltney SL; Sabat M; Tang M; Wang H; Jennings A; Hosfield D; Lee B; Wu Y; Halkowycz P; Grimshaw CE
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2678-2682. PubMed ID: 28512030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a potent, soluble glucokinase activator with increased pharmacokinetic half-life.
    Pike KG; Allen JV; Caulkett PW; Clarke DS; Donald CS; Fenwick ML; Johnson KM; Johnstone C; McKerrecher D; Rayner JW; Walker RP; Wilson I
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3467-70. PubMed ID: 21515051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and SAR of novel glucokinase activators.
    Cheruvallath ZS; Gwaltney SL; Sabat M; Tang M; Feng J; Wang H; Miura J; Guntupalli P; Jennings A; Hosfield D; Lee B; Wu Y
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2166-71. PubMed ID: 23434031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 2-pyridylureas as glucokinase activators.
    Hinklin RJ; Aicher TD; Anderson DA; Baer BR; Boyd SA; Condroski KR; DeWolf WE; Kraser CF; McVean M; Rhodes SP; Sturgis HL; Voegtli WC; Williams L; Houze JB
    J Med Chem; 2014 Oct; 57(19):8180-6. PubMed ID: 25203462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of 3,5-disubstituted benzamides as glucokinase activators with potent in vivo efficacy.
    Iino T; Hashimoto N; Sasaki K; Ohyama S; Yoshimoto R; Hosaka H; Hasegawa T; Chiba M; Nagata Y; Eiki J; Nishimura T
    Bioorg Med Chem; 2009 Jun; 17(11):3800-9. PubMed ID: 19427223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery, synthesis and biological evaluation of novel glucokinase activators.
    McKerrecher D; Allen JV; Bowker SS; Boyd S; Caulkett PW; Currie GS; Davies CD; Fenwick ML; Gaskin H; Grange E; Hargreaves RB; Hayter BR; James R; Johnson KM; Johnstone C; Jones CD; Lackie S; Rayner JW; Walker RP
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2103-6. PubMed ID: 15808477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct small-molecule kinase activation: Novel approaches for a new era of drug discovery.
    Simpson GL; Hughes JA; Washio Y; Bertrand SM
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):585-96. PubMed ID: 19736618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Activity Relationship of Azaindole-Based Glucokinase Activators.
    Paczal A; Bálint B; Wéber C; Szabó ZB; Ondi L; Theret I; De Ceuninck F; Bernard C; Ktorza A; Perron-Sierra F; Kotschy A
    J Med Chem; 2016 Jan; 59(2):687-706. PubMed ID: 26685731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motif.
    Filipski KJ; Guzman-Perez A; Bian J; Perreault C; Aspnes GE; Didiuk MT; Dow RL; Hank RF; Jones CS; Maguire RJ; Tu M; Zeng D; Liu S; Knafels JD; Litchfield J; Atkinson K; Derksen DR; Bourbonais F; Gajiwala KS; Hickey M; Johnson TO; Humphries PS; Pfefferkorn JA
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4571-8. PubMed ID: 23831135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel 2-(pyridine-2-yl)-1H-benzimidazole derivatives as potent glucokinase activators.
    Ishikawa M; Nonoshita K; Ogino Y; Nagae Y; Tsukahara D; Hosaka H; Maruki H; Ohyama S; Yoshimoto R; Sasaki K; Nagata Y; Eiki J; Nishimura T
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4450-4. PubMed ID: 19540111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of cycloalkyl-fused N-thiazol-2-yl-benzamides as tissue non-specific glucokinase activators: Design, synthesis, and biological evaluation.
    Wang Z; Shi X; Zhang H; Yu L; Cheng Y; Zhang H; Zhang H; Zhou J; Chen J; Shen X; Duan W
    Eur J Med Chem; 2017 Oct; 139():128-152. PubMed ID: 28800453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure based design, synthesis and biological evaluation of amino phosphonate derivatives as human glucokinase activators.
    Yellapu NK; Kilaru RB; Chamarthi N; Pvgk S; Matcha B
    Comput Biol Chem; 2017 Jun; 68():118-130. PubMed ID: 28327441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose modulation of glucokinase activation by small molecules.
    Ralph EC; Thomson J; Almaden J; Sun S
    Biochemistry; 2008 Apr; 47(17):5028-36. PubMed ID: 18370405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel and potent 2-amino benzamide derivatives as allosteric glucokinase activators.
    Nishimura T; Iino T; Mitsuya M; Bamba M; Watanabe H; Tsukahara D; Kamata K; Sasaki K; Ohyama S; Hosaka H; Futamura M; Nagata Y; Eiki J
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1357-60. PubMed ID: 19188063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
    Xu J; Lin S; Myers RW; Addona G; Berger JP; Campbell B; Chen HS; Chen Z; Eiermann GJ; Elowe NH; Farrer BT; Feng W; Fu Q; Kats-Kagan R; Kavana M; Malkani S; McMasters DR; Mitra K; Pachanski MJ; Tong X; Trujillo ME; Xu L; Zhang B; Zhang F; Zhang R; Parmee ER
    Bioorg Med Chem Lett; 2017 May; 27(9):2069-2073. PubMed ID: 28284804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling and identification of novel glucokinase activators through stepwise virtual screening.
    Behera PM; Behera DK; Satpati S; Agnihotri G; Nayak S; Padhi P; Dixit A
    J Mol Graph Model; 2015 Apr; 57():122-30. PubMed ID: 25723349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of potent and orally active 3-alkoxy-5-phenoxy-N-thiazolyl benzamides as novel allosteric glucokinase activators.
    Iino T; Tsukahara D; Kamata K; Sasaki K; Ohyama S; Hosaka H; Hasegawa T; Chiba M; Nagata Y; Eiki J; Nishimura T
    Bioorg Med Chem; 2009 Apr; 17(7):2733-43. PubMed ID: 19282189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.